![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Knabe, Ricarda; Muller, Philippe 
ORCID: https://orcid.org/0009-0000-0985-7666; Schliemann, Christoph ORCID: https://orcid.org/0000-0003-1755-9583; Hanoun, Maher ORCID: https://orcid.org/0000-0002-1754-8940; Unglaub, Julia Marie ORCID: https://orcid.org/0000-0002-3577-5493; Weinbergerová, Barbora ORCID: https://orcid.org/0000-0001-6460-2471; Mayer, Jiří; Krekeler, Carolin ORCID: https://orcid.org/0009-0000-1808-5928; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Kaufmann, Martin; Kraus, Sabrina ORCID: https://orcid.org/0000-0001-8954-4220; Steffen, Björn; Modemann, Franziska ORCID: https://orcid.org/0000-0002-5897-3310; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Rudelius, Martina ORCID: https://orcid.org/0000-0001-6928-9955; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Gutmair, Katja ORCID: https://orcid.org/0009-0002-3948-6186; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Herold, Tobias ORCID: https://orcid.org/0000-0002-9615-9432; Röllig, Christoph ORCID: https://orcid.org/0000-0002-3791-0548 und Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957
(2025):
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
In: Blood Advances, Bd. 9, Nr. 13: S. 3336-3339
[PDF, 1MB]
ORCID: https://orcid.org/0009-0000-0985-7666; Schliemann, Christoph ORCID: https://orcid.org/0000-0003-1755-9583; Hanoun, Maher ORCID: https://orcid.org/0000-0002-1754-8940; Unglaub, Julia Marie ORCID: https://orcid.org/0000-0002-3577-5493; Weinbergerová, Barbora ORCID: https://orcid.org/0000-0001-6460-2471; Mayer, Jiří; Krekeler, Carolin ORCID: https://orcid.org/0009-0000-1808-5928; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Kaufmann, Martin; Kraus, Sabrina ORCID: https://orcid.org/0000-0001-8954-4220; Steffen, Björn; Modemann, Franziska ORCID: https://orcid.org/0000-0002-5897-3310; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Bücklein, Veit L. ORCID: https://orcid.org/0000-0001-7391-7280; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Rudelius, Martina ORCID: https://orcid.org/0000-0001-6928-9955; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Gutmair, Katja ORCID: https://orcid.org/0009-0002-3948-6186; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Herold, Tobias ORCID: https://orcid.org/0000-0002-9615-9432; Röllig, Christoph ORCID: https://orcid.org/0000-0002-3791-0548 und Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957
(2025):
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
In: Blood Advances, Bd. 9, Nr. 13: S. 3336-3339
[PDF, 1MB]
Kunadt, Desiree; Stasik, Sebastian; Metzeler, Klaus H.; Roellig, Christoph; Schliemann, Christoph; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Scholl, Sebastian; Hilgendorf, Inken; Bruemmendorf, Tim H.; Jost, Edgar; Steffen, Bjoern; Bug, Gesine; Einsele, Hermann; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Krause, Stefan W.; Haenel, Mathias; Hanoun, Maher; Kaufmann, Martin; Woermann, Bernhard; Kramer, Michael; Sockel, Katja; Egger-Heidrich, Katharina; Herold, Tobias; Ehninger, Gerhard; Burchert, Andreas; Platzbecker, Uwe; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Hiddemann, Wolfgang; Serve, Hubert; Stelljes, Matthias; Baldus, Claudia D.; Neubauer, Andreas; Schetelig, Johannes; Thiede, Christian; Bornhaeuser, Martin; Middeke, Jan M. und Stoelzel, Friedrich
(2022):
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
In: Journal of Hematology & Oncology, Bd. 15, Nr. 1, 126
Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas und Middeke, Jan Moritz
(2021):
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
In: Blood Cancer Journal, Bd. 11, Nr. 10, 164